How reimbursement databases can be used to support drug utilisation studies: example using the main French national health insurance system database

被引:0
|
作者
Philippe Latry
Mathieu Molimard
Bernard Bégaud
Karin Martin-Latry
机构
[1] Echelon régional du service médical de l’assurance maladie d’Aquitaine,Département de Pharmacologie
[2] Université Victor Segalen Bordeaux 2,undefined
[3] Inserm U 657,undefined
[4] CHU,undefined
关键词
Databases; Pharmacoepidemiology; Health insurance; Reimbursement; France;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:743 / 748
页数:5
相关论文
共 11 条
  • [1] How reimbursement databases can be used to support drug utilisation studies: example using the main French national health insurance system database
    Latry, Philippe
    Molimard, Mathieu
    Begaud, Bernard
    Martin-Latry, Karin
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 66 (07) : 743 - 748
  • [2] How health technology reassessment can support disinvestment in China's national drug reimbursement list
    Shi, Lizheng
    Wu, Jiuhong
    Meng, Qingyue
    Li, Dakui
    BMJ-BRITISH MEDICAL JOURNAL, 2023, 381
  • [3] HOW CAN US GOVERNMENT CONTROL PHYSICIANS FEES UNDER NATIONAL HEALTH INSURANCE - LESSON FROM FRENCH SYSTEM
    THORSEN, LC
    INTERNATIONAL JOURNAL OF HEALTH SERVICES, 1974, 4 (01): : 49 - 57
  • [4] Agreement for drug exposure assessment between reimbursement data (French national health insurance database. CNAM-TS) and patient interviews in the framework of etiological studies: data from the Three-City (3C) cohort
    Noize, P.
    Bazin, F.
    Pariente, A.
    Begaud, B.
    Moore, N.
    Fourrier-Reglat, A.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2009, 23 : 89 - 89
  • [5] Prevalence and mortality of systemic sclerosis-associated interstitial lung disease (SSc-ILD) using the French national health insurance system (SNDS) database in France
    Nasser, Mouhamad
    Larrieu, Sophie
    Boussel, Loic
    Si-Mohamed, Salim
    Bazin, Fabienne
    Marque, Sebastien
    Massol, Jacques
    Revel, Didier
    Thivolet-Bejui, Francoise
    Chalabreysse, Lara
    Maucort-Boulch, Delphine
    Hachulla, Eric
    Jouneau, Stephane
    Cottin, Vincent
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [6] Association between gifts from pharmaceutical companies to French general practitioners and their drug prescribing patterns in 2016: retrospective study using the French Transparency in Healthcare and National Health Data System databases
    Goupil, Bruno
    Balusson, Frederic
    Naudet, Florian
    Esvan, Maxime
    Bastian, Benjamin
    Chapron, Anthony
    Frouard, Pierre
    BMJ-BRITISH MEDICAL JOURNAL, 2019, 367
  • [7] Association between gifts from pharmaceutical companies to French general practitioners and their drug prescribing patterns in 2016 Retrospective study using the French Transparency in Healthcare and National Health Data System databases
    Goupil, B.
    Balusson, F.
    Naudet, F.
    Esvan, M.
    Bastian, B.
    Chapron, A.
    Frouard, P.
    EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE, 2020, (159): : 18 - 20
  • [8] Emtricitabine/tenofovir (Truvada®) fixed-dose combination in pre-exposure prophylaxis of human immunodeficiency virus: An observational drug utilization study using the French national health insurance database
    de Gage, Sophie Billioti
    Raguideau, Fanny
    Rudnichi, Annie
    Dray-Spira, Rosemary
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 496 - 496
  • [9] Necessity for a System Implementing Therapeutic Drug Monitoring in Outpatient Settings Based on the Actual Use of Voriconazole Using the National Database of Health Insurance Claims and Specific Health Checkups of Japan: A Descriptive Epidemiological Study
    Muraki, Yuichi
    Koizumi, Ryuji
    Kusama, Yoshiki
    Inose, Ryo
    Ishikane, Masahiro
    Ohmagari, Norio
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2023, 46 (10) : 1490 - 1493